Table 1.
Diarrhea-associated morbidity and mortality in rabbit cohorts
| Parameter | Value or result fora: |
||
|---|---|---|---|
| Cohort 1 | Cohort 2 | Cohort 3 | |
| Rabbit population size | 1,385 | 123 | 839 |
| Source | Vendor 1 | Vendor 2 | Vendor 1 |
| Preshipment enrofloxacin prophylaxis | − | − | + |
| No. (%) of rabbits | |||
| Total diarrhea-associated morbidity | 145 (10.5) | 0 | 4 (0.477) |
| Full-course enrofloxacin-treated morbidity | 131 (9.46) | 0 | 3 (0.357) |
| Enrofloxacin-treated mortality | 13 (0.939) | 0 | 1 (0.119) |
| Total diarrhea-associated mortality | 20 (1.44) | 0 | 1 (0.119) |
a
Diarrhea-associated morbidity and mortality in three cohorts of Dutch Belted rabbits are shown. Cohort size, source, the use of preshipment enrofloxacin prophylaxis (−, not used; +, used), and total morbidity and mortality are shown. Diarrheic rabbits treated with 10 mg/kg enrofloxacin i.m. daily for 10 days are indicated in a separate row. Subsequent mortality following this treatment regimen is likewise separately shown. Percentage values are relative to rabbit population size.